Literature DB >> 3294833

Molecular weight of recombinant human tumor necrosis factor-alpha.

T Arakawa, D A Yphantis.   

Abstract

Recombinant DNA-derived human tumor necrosis factor-alpha from Escherichia coli was examined by equilibrium ultracentrifugation under conditions similar to those where gel filtration experiments suggested an oligomeric structure. Short-column equilibrium experiments at concentrations in the range 0.015-0.12% at pH 8.5 in 0.04 M Tris/Tris-HCl gave molecular weights corresponding to 3 times the sequence molecular weight both in the presence and absence of 0.1 M NaCl. Long (2.6 mm)-column experiments under the same solvent conditions indicated molecular weights of 51,900 +/- 900 in the absence of added NaCl and 52,600 +/- 700 in the presence of added 0.1 M NaCl. No evidence of any species other than the trimer was found.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3294833

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels.

Authors:  A Corti; G Fassina; F Marcucci; E Barbanti; G Cassani
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

3.  Recognition of human tumor necrosis factor α (TNF-α) by therapeutic antibody fragment: energetics and structural features.

Authors:  Jaka Marušič; Črtomir Podlipnik; Simona Jevševar; Drago Kuzman; Gorazd Vesnaver; Jurij Lah
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

4.  The limited proteolysis of tumor necrosis factor-alpha.

Authors:  L O Narhi; M F Rhode; P Hunt; T Arakawa
Journal:  J Protein Chem       Date:  1989-10

5.  Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.

Authors:  O M Howard; K A Clouse; C Smith; R G Goodwin; W L Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Effects of tumor necrosis factor and interferon-beta on proliferation and epidermal growth factor binding in young and senescent WI-38 cells.

Authors:  F L Cianciarulo; P D Phillips; V J Cristofalo
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-08       Impact factor: 2.416

7.  Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis.

Authors:  X Van Ostade; J Tavernier; T Prangé; W Fiers
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

Review 8.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.

Authors:  B Sherry; A Cerami
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

9.  Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.

Authors:  P Vandenabeele; W Declercq; D Vercammen; M Van de Craen; J Grooten; H Loetscher; M Brockhaus; W Lesslauer; W Fiers
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.